High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells.
about
Extracellular vesicles as mediators of vascular inflammation in kidney diseaseThe role of platelets in the recruitment of leukocytes during vascular diseaseClinical significance of procoagulant microparticlesMicroparticles as mediators and biomarkers of rheumatic diseaseBiomechanical factors and macrophages in plaque stabilityRole of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and ThrombosisEvaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columnsCD235a (Glycophorin-A) Is the Most Predictive Value Among Different Circulating Cellular Microparticles in Thrombocytopenic Human Immunodeficiency Virus Type 1.Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repairHDL interfere with the binding of T cell microparticles to human monocytes to inhibit pro-inflammatory cytokine production.The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.Interferons and interferon regulatory factors in malariaTheory to predict shear stress on cells in turbulent blood flow.Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicityLipoprotein-apheresis reduces circulating microparticles in individuals with familial hypercholesterolemia.Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.Circulating microparticles: square the circle.The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence.Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytesCirculating annexin V positive microparticles in patients after successful cardiopulmonary resuscitationMicroparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1The Role of Circulating Platelets Microparticles and Platelet Parameters in Acute Ischemic Stroke Patients.Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia.The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.Plasma microparticles and vascular disorders.Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement.The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles.Role of microparticles in atherothrombosis.Emerging hematological targets and therapy for cardiovascular disease: From bench to bedsideUpdate on pulmonary hypertension complicating chronic obstructive pulmonary diseaseProcoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.Comparison of the Protective Effects of Individual Components of Particulated trans-Sialidase (PTCTS), PTC and TS, against High Cholesterol Diet-Induced Atherosclerosis in Rabbits.Ectosomes as immunomodulators.Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.Association of microparticles and preeclampsia.Microparticles in health and disease.A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signalingAssociation between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices.
P2860
Q26765072-5F497719-5DE4-49AC-ACEF-73390B25962DQ26801407-604DF3A7-294B-487C-B13A-323B7727E60EQ26830846-8001F8E1-3142-4677-A309-E7BD1D3F8471Q27016054-D8772BA4-8BF5-4472-BAB3-85788106DFE1Q27693877-AEAA7011-5E9C-45CB-AA08-BCF14F37D1E9Q28069254-AE15BCA7-D865-4472-9C75-4E0E3B8A8156Q28222418-30295B87-3627-443A-B4A0-7877E766F891Q33420727-B2D4944A-48E9-4A2F-8C03-D3E3B2343D98Q33583258-6073D41C-A49C-4AB8-AEFB-489A9AB03965Q33649668-F15E6433-F9D7-47EA-A139-906DE1C6B261Q33916623-91DFC120-3F0D-4325-B201-49A46F5433DFQ34012443-E215BD0D-33CC-45AE-8217-C153571B9D3FQ34109972-F4065E33-7455-4968-B960-2CDB2FA4BCC7Q34195335-7AA582F7-557C-473D-86BA-7DAFEDDA3C57Q34238659-87A9630A-67ED-4A36-BE18-CE10E2682D43Q34442188-B6B33E41-57D9-4A27-B516-ADBD041639E6Q34680832-1768DC07-0CB9-461E-BEBD-3FE948F6C99AQ34996430-4B6AF6E2-FB52-4288-8612-05EF03AEF0A3Q35106116-5E64DE41-2C0C-49A3-AA8E-52B6C538F703Q35182740-2460A5D3-FDC9-403B-B760-48FAA44083D0Q35451359-69B5F808-F5A1-47B6-AB15-60EE081C6CF0Q35908304-8C5FCD6B-A6B2-4AEB-8400-69A33C021078Q36095677-95429B30-ADBD-4779-BA81-AF1581C819C2Q36119260-9AA12EAE-A5CD-4D5F-A7C1-D8F7AF748280Q36331121-49CE1B6A-4C27-44FC-BF6D-E25D65DAE136Q36445381-1C630D48-224F-4833-82A9-2209CCFBA397Q36759589-D98194E1-9DDA-47D5-ABE9-BE4F6D4C535DQ36785716-C242680D-26C5-4F06-A0A6-796F3975244BQ36898211-5750DE0B-C77C-4165-AB1E-6430D98C97C6Q37138036-39B67DFA-3B59-4AA5-9D2C-A5C038D221F2Q37290687-BCB1D555-A353-494F-9FC7-8F019E7A1546Q37367652-F338D73E-AC56-4BA1-A1DD-B19DC1275EBFQ37474995-E2CD5AE8-1D3A-4D50-89D1-43630D509EE0Q37700014-E4495FAC-FB53-4E71-A401-F81C2198ECAAQ37817007-1B12E243-9786-4D59-A6B2-17326EF8E062Q37922118-07E9FD00-E71F-4C47-BC32-E2824C00DE15Q38104276-078BA50A-2325-4A6F-8773-C5F3BEA3B115Q38118341-0E62AB28-848E-40BA-BED7-C765C2FC446CQ38321079-D98B646B-883D-45AF-8E75-D5024FA140A4Q38834342-41063DA0-9ACD-48C2-BED4-1F73D812E46A
P2860
High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
High-shear-stress-induced acti ...... n THP-1 and endothelial cells.
@ast
High-shear-stress-induced acti ...... n THP-1 and endothelial cells.
@en
type
label
High-shear-stress-induced acti ...... n THP-1 and endothelial cells.
@ast
High-shear-stress-induced acti ...... n THP-1 and endothelial cells.
@en
prefLabel
High-shear-stress-induced acti ...... n THP-1 and endothelial cells.
@ast
High-shear-stress-induced acti ...... n THP-1 and endothelial cells.
@en
P2093
P1433
P1476
High-shear-stress-induced acti ...... n THP-1 and endothelial cells.
@en
P2093
P304
P356
10.1016/S0021-9150(01)00433-6
P577
2001-10-01T00:00:00Z